| N6-methyladenine DNA modification in Drosophila G Zhang, H Huang, D Liu, Y Cheng, X Liu, W Zhang, R Yin, D Zhang, ... Cell 161 (4), 893-906, 2015 | 679 | 2015 |
| Bam-dependent deubiquitinase complex can disrupt germ-line stem cell maintenance by targeting cyclin A S Ji, C Li, L Hu, K Liu, J Mei, Y Luo, Y Tao, Z Xia, Q Sun, D Chen Proceedings of the National Academy of Sciences 114 (24), 6316-6321, 2017 | 51 | 2017 |
| 6mA-DNA-binding factor Jumu controls maternal-to-zygotic transition upstream of Zelda S He, G Zhang, J Wang, Y Gao, R Sun, Z Cao, Z Chen, X Zheng, J Yuan, ... Nature communications 10 (1), 2219, 2019 | 39 | 2019 |
| LC domain-mediated coalescence is essential for Otu enzymatic activity to extend Drosophila lifespan S Ji, Y Luo, Q Cai, Z Cao, Y Zhao, J Mei, C Li, P Xia, Z Xie, Z Xia, J Zhang, ... Molecular cell 74 (2), 363-377. e5, 2019 | 38 | 2019 |
| Proteolysis-targeting chimera against BCL-XL destroys tumor-infiltrating regulatory T cells R Kolb, U De, S Khan, Y Luo, MC Kim, H Yu, C Wu, J Mo, X Zhang, ... Nature communications 12 (1), 1281, 2021 | 37 | 2021 |
| Cancer cell-intrinsic function of CD177 in attenuating β-catenin signaling PN Kluz, R Kolb, Q Xie, N Borcherding, Q Liu, Y Luo, MC Kim, L Wang, ... Oncogene 39 (14), 2877-2889, 2020 | 15 | 2020 |
| PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy L Wang, Y Xiao, Y Luo, RP Master, J Mo, MC Kim, Y Liu, CK Maharjan, ... Journal of Experimental Medicine 221 (3), e20231519, 2024 | 2 | 2024 |
| A novel non-antibiotic selectable marker GASA6 for plant transformation Y Luo, J Gu, X Wang, S Zhang Plant Cell, Tissue and Organ Culture (PCTOC) 148 (3), 533-544, 2022 | 1 | 2022 |
| Unleashing the Power of NR4A1 Degradation as a Novel Strategy for Cancer Immunotherapy L Wang, Y Xiao, Y Luo, RP Master, J Mo, MC Kim, Y Liu, UM Patel, X Li, ... bioRxiv, 2023 | | 2023 |
| Proteolysis-targeting chimera against NR4A1 for cancer immunotherapy L Wang, Y Xiao, RP Master, Z Jin, UM Patel, Y Luo, D Zhou, G Zheng, ... Cancer Research 83 (7_Supplement), 2326-2326, 2023 | | 2023 |
| Developing a PROTAC-based NR4A1 degrader for melanoma cancer therapy R Master, Y Luo, Y Xiao, D Zhou, L Wang, G Zheng, W Zhang Cancer Research 83 (7_Supplement), 4451-4451, 2023 | | 2023 |
Shunmin HeProfessor, Center for Big Data Research in Health, Institute of Biophysics, CAS在 ibp.ac.cn 的电子邮件经过验证
